🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Hereditary Malignant Neoplasm

An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors NCT07371663Phase 1, Phase 23 sites📍 Beijing📍 Zhengzhou📍 Hangzhou Beijing Tide Pharmaceutical Co., Ltd · Tests: TCC1727 tablet 90mg, TCC1727 tablet 120mg, TCC1727 tablet 160mg, benmelstobart Injection Provider-Mediated Communication of Genetic Testing Results to At-Risk Relatives of Cancer Patients to Improve Genetic Counseling and Testing Rates, Family HOPE Study NCT05772130NA1 site📍 Duarte City of Hope Medical Center · Tests: Best Practice, Electronic Health Record Review, Personal Contact, Survey Administration Implementation of eHealth Delivery Alternatives for Cancer Genetic Testing for Hereditary Cancer (eREACH3) NCT07471958n/a1 site📍 Philadelphia Abramson Cancer Center at Penn Medicine Study of the Disease Process of Lymphangioleiomyomatosis NCT00001465n/a1 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) · Tests: Toshibia Aquilion One CT Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas NCT05253131Phase 21 site📍 Birmingham University of Alabama at Birmingham · Tests: Selumetinib + ZEN-3694 ± Durvalumab A Liquid Biopsy for Pancreatic Cancer Early-detection and Disease Monitoring NCT07700992n/a1 site📍 Milan Università Vita-Salute San Raffaele · Tests: PANXEON Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™ NCT05853783n/a5 sites📍 Birmingham📍 Loma Linda📍 Minneapolis Proteocyte Diagnostics Inc. · Tests: STRATICYTE™ Test Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment NCT05562778NA4 sites📍 Brooklyn📍 New York📍 New York Weill Medical College of Cornell University · Tests: Chatbot Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: biologic sample preservation procedure, cytology specimen collection procedure Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome NCT04920149Phase 28 sites📍 Aalborg📍 Hvidovre📍 Gothenburg Ann-Sofie Backman · Tests: Mesalamine, Placebo Implementation of Population Cancer Genetic Services in Federally Qualified Health Centers (FQHC) NCT05664867NA1 site📍 Chicago University of Illinois Chicago · Tests: Mainstream Genetic Testing Model, Enhanced Standard of Care Model Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors NCT07584499Phase 11 site📍 Guangzhou Sun Yat-sen University · Tests: Becotatug Vedotin European Rare Blood Disorders Platform (ENROL) NCT06250595n/a1 site📍 Barcelona Hospital Universitari Vall d'Hebron Research Institute · Tests: Collection of clinical and laboratory data from EHR. Institution of an Italian Registry and Biobank for Biological Sample Collection NCT06892964NA1 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: Genetic profiling of all eligible patients Questionnaire on Congenital Cancer Signs Through Self-Assessment NCT07378423NA1 site📍 Bern Insel Gruppe AG, University Hospital Bern · Tests: Pre-Visit Preparation (PVP) Brochure, QUOCCAS Questionnaire, Germline genetic sequencing for Cancer Predisposition Synd… Mechanisms of Somatic Mutation and Tumor Initiation in Pre-malignant Kidney Tubule Cells NCT06194669n/a1 site📍 Milan IRCCS San Raffaele · Tests: Blood and urine sample collection A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials NCT04064060Phase 3143 sites📍 Los Angeles📍 Oakland📍 Stanford Celgene · Tests: Luspatercept Pancreas Registry and High Risk Registry NCT02775461n/a2 sites📍 New York📍 New York Icahn School of Medicine at Mount Sinai A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors NCT05135975Phase 26 sites📍 Birmingham📍 Aurora📍 Washington D.C. Nationwide Children's Hospital · Tests: Cabozantinib EHR Intervention to Increase HBOC Genetic Testing NCT07876349NA1 site📍 New York Columbia University · Tests: ELISABETH Evidence-Informed Program (EIP) Prostate Cancer Genetic Risk Evaluation and Screening Study NCT05129605n/a1 site📍 Boston Massachusetts General Hospital · Tests: Prostate cancer screening Early Detection of Advanced Adenomas and Colorectal Cancer NCT06342440n/a6 sites📍 Monrovia📍 San Diego📍 Dalian City of Hope Medical Center · Tests: DENEB A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors NCT04657068Phase 1, Phase 288 sites📍 Birmingham📍 Scottsdale📍 Little Rock Artios Pharma Ltd · Tests: ART0380, Gemcitabine, Irinotecan Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI) NCT04743479n/a1 site📍 Shanghai Changhai Hospital · Tests: high-resolution MRI/CT examinations Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells NCT07148050Phase 11 site📍 Seattle Seattle Children's Hospital · Tests: SC-CAR.GPC3xIL15.21 CAR T cells Registry of Subjects at Risk of Pancreatic Cancer NCT04095195n/a4 sites📍 Rozzano📍 Peschiera del Garda📍 Milan Associazione Italiana per lo Studio del Pancreas · Tests: MRCP, Endoultrasonography AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion NCT04099966Phase 21 site📍 Valhalla Mitchell Cairo · Tests: alpha beta depletion Familial Investigations of Childhood Cancer Predisposition NCT03050268n/a1 site📍 Memphis St. Jude Children's Research Hospital Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST) NCT06222203n/a1 site📍 Bethesda National Cancer Institute (NCI) Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells NCT06198296Phase 11 site📍 Houston Baylor College of Medicine · Tests: 21.15.GPC3-CAR T cells
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy